Growth hormone (GH)/insulin-like growth factor 1 (IGF-1) axis abnormalities in multiple sclerosis (MS) suggest their role in its pathogenesis. Interferon β (IFN-β) efficacy could be mediated also by an increase of IGF-1 levels. A 2-year longitudinal study was performed to estimate the prevalence of GH and/or IGF-1 deficiency in clinically isolated syndrome (CIS) patients and their correlation with conversion to MS in IFN treated patients.

Growth hormone/IGF-1 axis longitudinal evaluation in clinically isolated syndrome patients on interferon β-1b therapy: stimulation tests and correlations with clinical and radiological conversion to multiple sclerosis / Lanzillo, Roberta; Di Somma, C; Quarantelli, M; Carotenuto, A; Pivonello, Claudia; Moccia, M; Cianflone, A; Marsili, A; Puorro, G; Sacca', Francesco; Russo, C. V; De Luca Picione, C; Ausiello, F; Colao, Annamaria; BRESCIA MORRA, Vincenzo. - In: EUROPEAN JOURNAL OF NEUROLOGY. - ISSN 1351-5101. - 24:2(2017), pp. 446-449-449. [10.1111/ene.13207]

Growth hormone/IGF-1 axis longitudinal evaluation in clinically isolated syndrome patients on interferon β-1b therapy: stimulation tests and correlations with clinical and radiological conversion to multiple sclerosis

LANZILLO, ROBERTA;Carotenuto, A;PIVONELLO, CLAUDIA;Moccia, M;SACCA', FRANCESCO;Russo, C. V;COLAO, ANNAMARIA;BRESCIA MORRA, VINCENZO
2017

Abstract

Growth hormone (GH)/insulin-like growth factor 1 (IGF-1) axis abnormalities in multiple sclerosis (MS) suggest their role in its pathogenesis. Interferon β (IFN-β) efficacy could be mediated also by an increase of IGF-1 levels. A 2-year longitudinal study was performed to estimate the prevalence of GH and/or IGF-1 deficiency in clinically isolated syndrome (CIS) patients and their correlation with conversion to MS in IFN treated patients.
2017
Growth hormone/IGF-1 axis longitudinal evaluation in clinically isolated syndrome patients on interferon β-1b therapy: stimulation tests and correlations with clinical and radiological conversion to multiple sclerosis / Lanzillo, Roberta; Di Somma, C; Quarantelli, M; Carotenuto, A; Pivonello, Claudia; Moccia, M; Cianflone, A; Marsili, A; Puorro, G; Sacca', Francesco; Russo, C. V; De Luca Picione, C; Ausiello, F; Colao, Annamaria; BRESCIA MORRA, Vincenzo. - In: EUROPEAN JOURNAL OF NEUROLOGY. - ISSN 1351-5101. - 24:2(2017), pp. 446-449-449. [10.1111/ene.13207]
File in questo prodotto:
File Dimensione Formato  
ms-gh_Lanzillo_2017.pdf

solo utenti autorizzati

Tipologia: Documento in Post-print
Licenza: Accesso privato/ristretto
Dimensione 137.83 kB
Formato Adobe PDF
137.83 kB Adobe PDF   Visualizza/Apri   Richiedi una copia

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11588/661063
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus 2
  • ???jsp.display-item.citation.isi??? 2
social impact